{"symbol": "TRIL", "companyName": "Trillium Therapeutics Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.trilliumtherapeutics.com", "description": "Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.", "CEO": "Niclas Stiernholm", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}